Institute of Public Health and Clinical Nutrition - News

The serum metabolite profile can be used to identify individuals likely at risk of developing an alcohol-related disease in the future.

Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects.

Many Finns are risk takers when it comes to alcohol. Reaching middle age can be a turning point – or the end of the line.